Eaton Vance Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $22.8M | Buy |
|
|||||
|
2022
Q2 | $19M | Buy |
|
|||||
|
2022
Q1 | $9.82M | Sell |
|
|||||
|
2021
Q4 | $20.1M | Buy |
|
|||||
|
2021
Q3 | $22.2M | Buy |
|
|||||
|
2021
Q2 | $23.1M | Sell |
|
|||||
|
2021
Q1 | $23.3M | Buy |
|
|||||
|
2020
Q4 | $23.3M | Sell |
|
|||||
|
2020
Q3 | $22.4M | Sell |
|
|||||
|
2020
Q2 | $23.5M | Sell |
|
|||||
|
2020
Q1 | $17.3M | Buy |
|
|||||
|
2019
Q4 | $17.6M | Buy |
|
|||||
|
2019
Q3 | $13.9M | Buy |
|
|||||
|
2019
Q2 | $15.1M | Buy |
|
|||||
|
2019
Q1 | $14.6M | Buy |
|
|||||
|
2018
Q4 | $7.96M | Sell |
|
|||||
|
2018
Q3 | $11.3M | Buy |
|
|||||
|
2018
Q2 | $9.53M | Sell |
|
|||||
|
2018
Q1 | $15.2M | Buy |
|
|||||
|
2017
Q4 | $6.31M | Buy |
|
|||||
|
2017
Q3 | $3.09M | Buy |
|
|||||
|
2017
Q2 | $1.65M | Buy |
|